Table 6

Cumulative Incidence of Clinical Outcomes by Quartiles of Total Stent Length per Lesion During 3-Year Follow-Up

Quartile 1 (8–18 mm)Quartile 2 (18–20 mm)Quartile 3 (20–27 mm)Quartile 4 (≥27 mm)p Value
n = 1,014 (19.0%)n = 1,601 (31.0%)n = 1,143 (22.0%)n = 1,474 (28.0%)
MACE
 0–3 yrs99 (11.97%)165 (11.73%)136 (13.93%)229 (18.19%)<0.0001
 0–1 yr69 (6.86%)90 (5.67%)106 (9.38%)182 (12.46%)<0.0001
 1–3 yrs30 (5.49%)75 (6.43%)30 (5.02%)47 (6.55%)0.5383
Key safety endpoint
 0–3 yrs68 (8.24%)99 (7.09%)84 (8.47%)158 (12.27%)<0.0001
 0–1 yr49 (4.86%)52 (3.27%)67 (5.90%)130 (8.88%)<0.0001
 1–3 yrs19 (3.55%)47 (3.95%)17 (2.73%)28 (3.73%)0.5975
All-cause death or MI
 0–3 yrs65 (7.93%)98 (7.03%)84 (8.47%)156 (12.22%)<0.0001
 0–1 yr46 (4.56%)51 (3.21%)67 (5.90%)127 (8.67%)<0.0001
 1–3 yrs19 (3.53%)47 (3.95%)17 (2.73%)29 (3.89%)0.5774
All-cause death
 0–3 yrs39 (5.09%)58 (4.31%)52 (5.66%)68 (6.05%)0.1020
 0–1 yr23 (2.29%)21 (1.33%)34 (3.00%)41 (2.81%)0.0112
 1–3 yrs16 (2.86%)37 (3.02%)18 (2.74%)27 (3.33%)0.9107
Cardiac death
 0–3 yrs21 (2.70%)25 (3.13%)35 (3.96%)36 (4.40%)0.2992
 0–1 yr15 (1.58%)14 (1.43%)27 (2.59%)24 (2.04%)0.2161
 1–3 yrs6 (1.14%)11 (1.72%)8 (1.40%)12 (2.40%)0.5654
MI
 0–3 yrs30 (3.39%)49 (3.35%)41 (3.84%)99 (7.13%)<0.0001
 0–1 yr26 (2.58%)36 (2.26%)38 (3.35%)93 (6.36%)<0.0001
 1–3 yrs4 (0.83%)13 (1.11%)3 (0.51%)6 (0.82%)0.5967
Definite/probable ST
 0–3 yrs10 (1.12%)18 (1.22%)4 (0.36%)20 (1.52%)0.0693
 0–1 yr9 (0.90%)12 (0.75%)4 (0.36%)17 (1.18%)0.1431
 1–3 yrs1 (0.23%)6 (0.47%)0 (0.00%)3 (0.35%)0.2706
TLR
 0–3 yrs44 (5.24%)86 (6.05%)58 (6.23%)96 (8.13%)0.0507
 0–1 yr32 (3.23%)52 (3.29%)44 (3.98%)70 (4.90%)0.0855
 1–3 yrs12 (2.07%)34 (2.86%)14 (2.35%)26 (3.41%)0.4540

The key safety endpoint was defined as a composite of all-cause death, myocardial infarction, or definite or probable ST.

Abbreviations as in Tables 1 and 3.